Latest Articles
Edinburgh woman, 28, faces hysterectomy in battle with debilitating condition - Yahoo News UK
Edinburgh woman, 28, faces hysterectomy in battle with debilitating condition Yahoo News UK
Published: Nov. 2, 2025, 6 a.m.
Edinburgh woman, 28, faces hysterectomy in battle with debilitating condition - Edinburgh Live
Edinburgh woman, 28, faces hysterectomy in battle with debilitating condition Edinburgh Live
Published: Nov. 2, 2025, 6 a.m.
Genetic variation associated with side effects of hormonal contraception exposure: A narrative review - Frontiers
Genetic variation associated with side effects of hormonal contraception exposure: A narrative review Frontiers
Published: Oct. 30, 2025, 5:03 p.m.
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - MSN
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment MSN
Published: Oct. 30, 2025, 11:45 a.m.
Bacterial Extracellular Vesicles and Their Role in PCOS and Endometriosis Explained - News-Medical
Bacterial Extracellular Vesicles and Their Role in PCOS and Endometriosis Explained News-Medical
Published: Oct. 30, 2025, 3:46 a.m.
The Menopause Issue 2025 - Flow Space
The Menopause Issue 2025 Flow Space
Published: Oct. 29, 2025, 4:18 p.m.
The Change That Isn’t? Why Endometriosis Can Follow You Into Menopause - Flow Space
The Change That Isn’t? Why Endometriosis Can Follow You Into Menopause Flow Space
Published: Oct. 29, 2025, 4 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 28, 2025, 5:03 a.m.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health - MedCity News
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health MedCity News
Published: Oct. 27, 2025, 10:24 p.m.
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment - TipRanks
Kissei Pharmaceutical’s Promising Phase III Study on Endometriosis Treatment TipRanks
Published: Oct. 27, 2025, 6:32 p.m.
Link copied to clipboard!